Justyn Y. Nakashima

Radiation Oncology

New York, NY 10087

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-Preserving Trimodality Therapy.

Early Detection of Metastatic Progression by Circulating Tumor DNA in Patients Undergoing Bladder-Preserving Trimodality Therapy.

Journal: The Journal of urology

Published: November 13, 2025

Case Report: Early experience with hypoxia-targeted SBRT-based partial tumor irradiation in large and bulky tumors.

Case Report: Early experience with hypoxia-targeted SBRT-based partial tumor irradiation in large and bulky tumors.

Journal: Frontiers in oncology

Published: September 02, 2025

To irradiate or electroporate: how should we ablate pancreatic cancer?

To irradiate or electroporate: how should we ablate pancreatic cancer?

Journal: Translational gastroenterology and hepatology

Published: December 17, 2024

The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma.

The Evolving Role of Neoadjuvant Radiation Therapy in Pancreatic Adenocarcinoma.

Journal: Journal of clinical medicine

Published: October 12, 2024

Impact of Myc-Altered Pathology on Radiation Therapy Efficacy Among Patients With Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Study by ILROG.

Impact of Myc-Altered Pathology on Radiation Therapy Efficacy Among Patients With Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Study by ILROG.

Journal: International journal of radiation oncology, biology, physics

Published: August 21, 2024

Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.

Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases.

Journal: NPJ breast cancer

Published: July 29, 2024

Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes.

Tumor burden quantified by soluble B-cell maturation antigen and metabolic tumor volume determines myeloma CAR-T outcomes.

Journal: Blood

Published: April 11, 2024

Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.

Clinical outcomes of melanoma brain metastases treated with nivolumab and ipilimumab alone versus nivolumab and ipilimumab with stereotactic radiosurgery.

Journal: Journal of neuro-oncology

Published: November 26, 2023

Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases.

Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 22, 2023

Association between transcriptomic metrics of exogenous antigen presentation and adaptive immunity with locoregional recurrence in localized estrogen receptor negative breast cancer: retrospective review of multi-institutional datasets.

Association between transcriptomic metrics of exogenous antigen presentation and adaptive immunity with locoregional recurrence in localized estrogen receptor negative breast cancer: retrospective review of multi-institutional datasets.

Journal: Breast cancer research : BCR

Published: June 13, 2023

Showing 1-10 of 10

Last Updated: 09/26/2026